Table 3.
Age- and sex-specific 10-, 20-, 30-, and 40-year and lifetime risk estimates (in percentage) for ESRD by level of kidney function
Kidney Function | Sex | Index Age (Years) | Short- and Intermediate-Term Risk (Years) | Lifetime Risk | |||
---|---|---|---|---|---|---|---|
10 | 20 | 30 | 40 | ||||
Unadjusted for competing risk of death | |||||||
eGFR≥90 | Men | 40 | 0.09 (0.06–0.11) | 0.24 (0.20–0.29) | 0.54 (0.45–0.64) | 0.93 (0.62–1.24) | 0.95 (0.63–1.24) |
eGFR≥90 | Men | 50 | 0.16 (0.12–0.19) | 0.46 (0.37–0.55) | 0.84 (0.54–1.15) | 0.85 (0.54–1.15) | |
eGFR≥90 | Men | 60 | 0.29 (0.21–0.38) | 0.68 (0.38–0.99) | 0.69 (0.38–0.99) | ||
eGFR≥90 | Men | 70 | 0.39 (0.09–0.68) | 0.40 (0.10–0.69) | |||
eGFR≥90 | Women | 40 | 0.07 (0.05–0.09) | 0.18 (0.15–0.22) | 0.35 (0.28–0.42) | 0.66 (0.45–0.87) | 0.88 (0.40–1.36) |
eGFR≥90 | Women | 50 | 0.11 (0.08–0.14) | 0.28 (0.21–0.34) | 0.58 (0.38–0.79) | 0.80 (0.33–1.28) | |
eGFR≥90 | Women | 60 | 0.17 (0.11–0.22) | 0.47 (0.27–0.68) | 0.69 (0.22–1.17) | ||
eGFR≥90 | Women | 70 | 0.31 (0.11–0.51) | 0.53 (0.05–1.00) | |||
eGFR=60–89 | Men | 40 | 0.12 (0.08–0.16) | 0.29 (0.23–0.34) | 0.54 (0.47–0.61) | 0.94 (0.84–1.04) | 1.27 (1.11–1.42) |
eGFR=60–89 | Men | 50 | 0.17 (0.13–0.21) | 0.42 (0.36–0.48) | 0.82 (0.73–0.91) | 1.15 (1.00–1.30) | |
eGFR=60–89 | Men | 60 | 0.25 (0.20–0.30) | 0.65 (0.57–0.74) | 0.99 (0.86–1.18) | ||
eGFR=60–89 | Men | 70 | 0.40 (0.33–0.47) | 0.73 (0.61–0.92) | |||
eGFR=60–89 | Women | 40 | 0.09 (0.06–0.13) | 0.21 (0.16–0.25) | 0.38 (0.32–0.44) | 0.57 (0.50–0.65) | 0.71 (0.62–0.81) |
eGFR=60–89 | Women | 50 | 0.11 (0.08–0.14) | 0.28 (0.23–0.33) | 0.48 (0.41–0.55) | 0.62 (0.53–0.71) | |
eGFR=60–89 | Women | 60 | 0.17 (0.13–0.21) | 0.37 (0.31–0.43) | 0.51 (0.42–0.59) | ||
eGFR=60–89 | Women | 70 | 0.20 (0.15–0.25) | 0.33 (0.26–0.41) | |||
eGFR=45–59 | Men | 40 | 3.39 (1.91–4.87) | 5.37 (3.80–6.94) | 6.77 (5.18–8.36) | 7.86 (6.27–9.45) | 8.63 (7.04–10.22) |
eGFR=45–59 | Men | 50 | 2.05 (1.42–2.69) | 3.50 (2.77–4.23) | 4.63 (3.87–5.39) | 5.42 (4.63–6.21) | |
eGFR=45–59 | Men | 60 | 1.47 (1.09–1.86) | 2.63 (2.18–3.08) | 3.44 (2.94–3.94) | ||
eGFR=45–59 | Men | 70 | 1.18 (0.92–1.43) | 2.00 (1.65–2.34) | |||
eGFR=45–59 | Women | 40 | 1.24 (0.46–2.02) | 2.00 (1.13–2.87) | 2.75 (1.85–3.64) | 3.34 (2.44–4.24) | 3.59 (2.68–4.49) |
eGFR=45–59 | Women | 50 | 0.78 (0.37–1.16) | 1.52 (1.06–1.98) | 2.12 (1.64–2.61) | 2.37 (1.87–2.87) | |
eGFR=45–59 | Women | 60 | 0.76 (0.51–1.01) | 1.37 (1.07–1.66) | 1.62 (1.31–1.92) | ||
eGFR=45–59 | Women | 70 | 0.61 (0.45–0.77) | 0.86 (0.67–1.06) | |||
eGFR 30–44 | Men | 40 | 24.57 (16.95–32.19) | 40.07 (33.11–47.04) | 47.90 (41.66–54.13) | 51.20 (45.33–57.06) | 52.43 (46.71–58.16) |
eGFR=30–44 | Men | 50 | 20.55 (15.99–25.11) | 30.92 (26.50–35.34) | 35.30 (31.08–39.51) | 36.94 (32.81–41.06) | |
eGFR=30–44 | Men | 60 | 13.05 (10.59–15.52) | 18.56 (16.06–21.07) | 20.63 (18.13–23.13) | ||
eGFR=30–44 | Men | 70 | 6.34 (5.21–7.46) | 9.21 (7.87–10.56) | |||
eGFR=30–44 | Women | 40 | 13.58 (7.72–19.43) | 22.91 (16.89–28.92) | 27.77 (21.99–33.54) | 29.81 (24.18–35.45) | 30.40 (24.81–35.99) |
eGFR=30–44 | Women | 50 | 10.80 (7.35–14.24) | 16.42 (12.88–19.96) | 18.79 (15.30–22.28) | 19.46 (16.00–22.93) | |
eGFR=30–44 | Women | 60 | 6.31 (4.68–7.94) | 8.96 (7.25–10.67) | 9.72 (8.00–11.43) | ||
eGFR=30–44 | Women | 70 | 2.83 (2.14–3.52) | 3.64 (2.90–4.37) | |||
Adjusted for competing risk of death | |||||||
eGFR≥90 | Men | 40 | 0.09 (0.06–0.11) | 0.24 (0.19–0.28) | 0.49 (0.41–0.57) | 0.71 (0.53–0.89) | 0.72 (0.54–0.89) |
eGFR≥90 | Men | 50 | 0.16 (0.12–0.19) | 0.41 (0.33–0.50) | 0.64 (0.46–0.82) | 0.65 (0.47–0.83) | |
eGFR≥90 | Men | 60 | 0.28 (0.20–0.35) | 0.52 (0.33–0.71) | 0.53 (0.34–0.71) | ||
eGFR≥90 | Men | 70 | 0.29 (0.08–0.49) | 0.30 (0.09–0.50) | |||
eGFR≥90 | Women | 40 | 0.07 (0.05–0.09) | 0.18 (0.15–0.21) | 0.33 (0.27–0.39) | 0.56 (0.41–0.72) | 0.67 (0.41–0.94) |
eGFR≥90 | Women | 50 | 0.11 (0.08–0.14) | 0.26 (0.20–0.32) | 0.50 (0.34–0.66) | 0.60 (0.34–0.88) | |
eGFR≥90 | Women | 60 | 0.16 (0.11–0.22) | 0.41 (0.24–0.57) | 0.52 (0.24–0.80) | ||
eGFR≥90 | Women | 70 | 0.27 (0.10–0.44) | 0.40 (0.10–0.69) | |||
eGFR=60–89 | Men | 40 | 0.12 (0.08–0.16) | 0.28 (0.23–0.33) | 0.51 (0.44–0.58) | 0.83 (0.74–0.92) | 1.01 (0.90–1.11) |
eGFR=60–89 | Men | 50 | 0.17 (0.13–0.20) | 0.40 (0.34–0.46) | 0.73 (0.64–0.81) | 0.90 (0.80–1.00) | |
eGFR=60–89 | Men | 60 | 0.25 (0.20–0.29) | 0.58 (0.50–0.66) | 0.76 (0.67–0.86) | ||
eGFR=60–89 | Men | 70 | 0.36 (0.30–0.43) | 0.58 (0.48–0.66) | |||
eGFR=60–89 | Women | 40 | 0.09 (0.06–0.13) | 0.20 (0.16–0.25) | 0.36 (0.30–0.42) | 0.53 (0.46–0.61) | 0.63 (0.54–0.71) |
eGFR=60–89 | Women | 50 | 0.11 (0.08–0.14) | 0.27 (0.23–0.32) | 0.45 (0.38–0.51) | 0.45 (0.38–0.51) | |
eGFR=60–89 | Women | 60 | 0.17 (0.13–0.21) | 0.34 (0.29–0.40) | 0.44 (0.37–0.51) | ||
eGFR=60–89 | Women | 70 | 0.19 (0.15–0.23) | 0.29 (0.23–0.35) | |||
eGFR=45–59 | Men | 40 | 3.35 (1.88–4.81) | 5.19 (3.64–6.75) | 6.38 (4.80–7.95) | 7.14 (5.58–8.71) | 7.51 (5.95–9.08) |
eGFR=45–59 | Men | 50 | 1.96 (1.35–2.57) | 3.21 (2.53–3.90) | 4.03 (3.33–4.73) | 4.42 (3.71–5.13) | |
eGFR=45–59 | Men | 60 | 1.40 (1.04–1.77) | 2.32 (1.90–2.73) | 2.75 (2.32–3.18) | ||
eGFR=45–59 | Men | 70 | 1.06 (0.83–1.29) | 1.56 (1.29–1.83) | |||
eGFR=45–59 | Women | 40 | 1.23 (0.46–2.00) | 1.95 (1.10–2.81) | 2.61 (1.73–3.48) | 3.07 (2.19–3.95) | 3.21 (2.33–4.09) |
eGFR=45–59 | Women | 50 | 0.75 (0.36–1.14) | 1.44 (0.99–1.89) | 1.92 (1.45–2.39) | 2.07 (1.60–2.54) | |
eGFR=45–59 | Women | 60 | 0.73 (0.49–0.98) | 1.26 (0.98–1.53) | 1.42 (1.13–1.70) | ||
eGFR=45–59 | Women | 70 | 0.57 (0.42–0.73) | 0.75 (0.58–0.92) | |||
eGFR=30–44 | Men | 40 | 26.87 (18.43–35.30) | 44.60 (36.98–52.30) | 52.64 (45.85–59.43) | 55.05 (48.58–61.51) | 55.54 (49.14–61.93) |
eGFR=30–44 | Men | 50 | 20.57 (15.91–25.23) | 29.82 (25.27–34.38) | 32.62 (28.19–37.05) | 33.18 (28.78–37.59) | |
eGFR=30–44 | Men | 60 | 11.98 (9.61–14.34) | 15.59 (13.21–17.98) | 16.32 (13.94–18.71) | ||
eGFR=30–44 | Men | 70 | 5.36 (4.36–6.36) | 6.44 (5.41–7.47) | |||
eGFR=30–44 | Women | 40 | 13.68 (7.68–19.67) | 22.96 (16.74–29.18) | 27.13 (21.09–33.16) | 28.55 (22.60–34.49) | 28.81 (22.88–34.73) |
eGFR=30–44 | Women | 50 | 10.69 (7.16–14.22) | 15.49 (11.85–19.13) | 17.13 (13.51–20.74) | 17.43 (13.81–21.04) | |
eGFR=30–44 | Women | 60 | 5.84 (4.30–7.38) | 7.83 (6.24–9.42) | 8.19 (6.60–9.78) | ||
eGFR=30–44 | Women | 70 | 2.58 (1.93–3.23) | 3.05 (2.39–3.72) |